| 36.55 Delayed Data As of 6:30pm ET |  -0.45 / -1.22%Today’s Change | 30.99 Today|||52-Week Range 42.75 | +12.84% Year-to-Date |
| Here’s Why FibroGen’s Stock Popped Friday Nov 11 / MotleyFool.com - Paid Partner Content | Cara Therapeutics Q3 Update: Forget the Financials and Focus on the Pipeline Nov 06 / MotleyFool.com - Paid Partner Content |
| Previous close | 37.00 |
| Today’s open | 36.66 |
| Day’s range | 36.50 - 36.77 |
| Volume | 121,895 |
| Average volume (3 months) | 210,596 |
| Market cap | $22.7B |
| Earnings growth (last year) | +60.51% |
| Earnings growth (this year) | -7.89% |
| Earnings growth (next 5 years) | +7.03% |
| Revenue growth (last year) | -3.67% |
| P/E ratio | 15.8 |
| Price/Sales | 1.02 |
| Price/Book | 1.72 |
| Next reporting date | February 20, 2020 |
| EPS forecast (this quarter) | $0.67 |
| Annual revenue (last year) | $19.5B |
| Annual profit (last year) | $2.3B |
| Net profit margin | 11.98% |
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Bad Homburg, Hessen |
